Radiopharm Theranostics (ASX:RAD) Buyback Yield %: -163.03 (As of Jul. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Radiopharm Theranostics Buyback Yield %?

Radiopharm Theranostics ASX:RAD Buyback Yield % is -163.03 as of Jul. 31, 2026. The stock has 5 warning signs investors should review. Among 735 Biotechnology companies, Radiopharm Theranostics ranks worse than 93.2% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Radiopharm Theranostics's current buyback yield was -163.03%.

Radiopharm Theranostics Buyback Yield % Related Terms

Radiopharm Theranostics Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Radiopharm Theranostics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Radiopharm Theranostics Buyback Yield % Chart

Radiopharm Theranostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Buyback Yield %
-182.70 -28.27 -169.46 -103.75

Radiopharm Theranostics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Buyback Yield % Get a 7-Day Free Trial -28.27 -7.69 -169.46 -139.07 -103.75

ASX:RAD vs VRTX, REGN, RVMD: Buyback Yield % Comparison

For the Biotechnology subindustry, Radiopharm Theranostics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Radiopharm Theranostics Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Radiopharm Theranostics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Radiopharm Theranostics's Buyback Yield % falls into.


Radiopharm Theranostics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Radiopharm Theranostics's Buyback Yield for the fiscal year that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 53.978) / 52.0289
=-103.75%

Radiopharm Theranostics's annualized Buyback Yield for the quarter that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 53.978) / 52.0289
=-103.75%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -163.03 mean?
Radiopharm Theranostics (ASX:RAD) has a Buyback Yield % of -163.03 as of Jul. 31, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Radiopharm Theranostics and its competitors. According to the industry distribution chart, Radiopharm Theranostics ranks #685 out of 735 companies in the Biotechnology industry, placing it in the top 93.2%.
Is Radiopharm Theranostics' Buyback Yield % too high?
Radiopharm Theranostics' current Buyback Yield % is -163.03. Based on the distribution chart, Radiopharm Theranostics ranks #685 out of 735 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Radiopharm Theranostics' Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Radiopharm Theranostics ranks #685 out of 735 companies for Buyback Yield %. This places Radiopharm Theranostics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Radiopharm Theranostics and its competitors. Radiopharm Theranostics's current Buyback Yield % is -163.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Radiopharm Theranostics stock overvalued right now?
Radiopharm Theranostics (ASX:RAD) has a current Buyback Yield % of -163.03. The current Buyback Yield % is -163.03. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Radiopharm Theranostics (ASX:RAD), the current Buyback Yield % is -163.03 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Radiopharm Theranostics Business Description

Other Exchanges RADX:USA
Address 62 Lygon Street, Suite 1, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.